![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: BRD9 |
Gene summary for BRD9 |
![]() |
Gene information | Species | Human | Gene symbol | BRD9 | Gene ID | 65980 |
Gene name | bromodomain containing 9 | |
Gene Alias | LAVS3040 | |
Cytomap | 5p15.33 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | B4DXI2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
65980 | BRD9 | LZE5T | Human | Esophagus | ESCC | 3.20e-09 | 5.76e-01 | 0.0514 |
65980 | BRD9 | LZE7T | Human | Esophagus | ESCC | 2.31e-04 | 1.37e-01 | 0.0667 |
65980 | BRD9 | LZE8T | Human | Esophagus | ESCC | 1.47e-03 | 1.02e-01 | 0.067 |
65980 | BRD9 | LZE20T | Human | Esophagus | ESCC | 4.15e-11 | 4.32e-01 | 0.0662 |
65980 | BRD9 | LZE21D1 | Human | Esophagus | HGIN | 2.30e-08 | 5.76e-01 | 0.0632 |
65980 | BRD9 | LZE22D1 | Human | Esophagus | HGIN | 7.91e-07 | 3.17e-01 | 0.0595 |
65980 | BRD9 | LZE22T | Human | Esophagus | ESCC | 1.22e-11 | 7.98e-01 | 0.068 |
65980 | BRD9 | LZE24T | Human | Esophagus | ESCC | 1.20e-12 | 2.72e-01 | 0.0596 |
65980 | BRD9 | LZE22D3 | Human | Esophagus | HGIN | 1.31e-04 | 5.76e-01 | 0.0653 |
65980 | BRD9 | LZE21T | Human | Esophagus | ESCC | 1.97e-12 | 4.90e-01 | 0.0655 |
65980 | BRD9 | P1T-E | Human | Esophagus | ESCC | 1.94e-26 | 1.06e+00 | 0.0875 |
65980 | BRD9 | P2T-E | Human | Esophagus | ESCC | 2.69e-25 | 4.98e-01 | 0.1177 |
65980 | BRD9 | P4T-E | Human | Esophagus | ESCC | 1.74e-24 | 5.82e-01 | 0.1323 |
65980 | BRD9 | P5T-E | Human | Esophagus | ESCC | 6.75e-29 | 6.13e-01 | 0.1327 |
65980 | BRD9 | P8T-E | Human | Esophagus | ESCC | 9.70e-35 | 5.77e-01 | 0.0889 |
65980 | BRD9 | P9T-E | Human | Esophagus | ESCC | 1.11e-26 | 5.84e-01 | 0.1131 |
65980 | BRD9 | P10T-E | Human | Esophagus | ESCC | 2.12e-60 | 1.04e+00 | 0.116 |
65980 | BRD9 | P11T-E | Human | Esophagus | ESCC | 1.03e-12 | 4.26e-01 | 0.1426 |
65980 | BRD9 | P12T-E | Human | Esophagus | ESCC | 7.77e-26 | 4.52e-01 | 0.1122 |
65980 | BRD9 | P15T-E | Human | Esophagus | ESCC | 3.95e-13 | 3.24e-01 | 0.1149 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000632516 | Esophagus | HGIN | chromatin organization | 92/2587 | 409/18723 | 1.05e-06 | 4.16e-05 | 92 |
GO:000632517 | Esophagus | ESCC | chromatin organization | 240/8552 | 409/18723 | 6.52e-08 | 1.14e-06 | 240 |
GO:000632511 | Liver | HCC | chromatin organization | 206/7958 | 409/18723 | 7.23e-04 | 4.41e-03 | 206 |
GO:000632510 | Oral cavity | OSCC | chromatin organization | 190/7305 | 409/18723 | 1.17e-03 | 5.97e-03 | 190 |
GO:000632514 | Prostate | Tumor | chromatin organization | 104/3246 | 409/18723 | 2.02e-05 | 2.62e-04 | 104 |
GO:000632518 | Skin | AK | chromatin organization | 73/1910 | 409/18723 | 1.40e-06 | 4.26e-05 | 73 |
GO:000632519 | Skin | cSCC | chromatin organization | 147/4864 | 409/18723 | 4.41e-06 | 6.52e-05 | 147 |
GO:000632520 | Thyroid | PTC | chromatin organization | 183/5968 | 409/18723 | 2.55e-08 | 5.70e-07 | 183 |
GO:0006325110 | Thyroid | ATC | chromatin organization | 189/6293 | 409/18723 | 6.40e-08 | 1.13e-06 | 189 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
BRD9 | SNV | Missense_Mutation | novel | c.1213G>C | p.Glu405Gln | p.E405Q | Q9H8M2 | protein_coding | deleterious(0.03) | possibly_damaging(0.794) | TCGA-CV-A461-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
BRD9 | SNV | Missense_Mutation | rs758871899 | c.1705N>T | p.Arg569Cys | p.R569C | Q9H8M2 | protein_coding | deleterious_low_confidence(0) | benign(0.245) | TCGA-CV-A6K2-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
BRD9 | SNV | Missense_Mutation | c.469N>T | p.Pro157Ser | p.P157S | Q9H8M2 | protein_coding | deleterious(0) | benign(0.184) | TCGA-G9-6365-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 7 | Unknown | Unknown | SD | |
BRD9 | SNV | Missense_Mutation | rs145491306 | c.1012N>A | p.Val338Met | p.V338M | Q9H8M2 | protein_coding | deleterious(0) | probably_damaging(0.915) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
BRD9 | SNV | Missense_Mutation | rs748289899 | c.872N>T | p.Thr291Met | p.T291M | Q9H8M2 | protein_coding | deleterious(0.03) | benign(0.413) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
BRD9 | SNV | Missense_Mutation | rs763145611 | c.946C>T | p.Arg316Trp | p.R316W | Q9H8M2 | protein_coding | deleterious(0) | probably_damaging(0.939) | TCGA-F1-6177-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
BRD9 | SNV | Missense_Mutation | novel | c.580N>A | p.Glu194Lys | p.E194K | Q9H8M2 | protein_coding | tolerated(0.09) | possibly_damaging(0.592) | TCGA-VQ-A8PB-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | fluorouracil | CR |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
65980 | BRD9 | ENZYME | inhibitor | 252166773 | ||
65980 | BRD9 | ENZYME | inhibitor | 310264731 | ||
65980 | BRD9 | ENZYME | inhibitor | 336446908 | ||
65980 | BRD9 | ENZYME | 387065623 | |||
65980 | BRD9 | ENZYME | inhibitor | 252166608 | ||
65980 | BRD9 | ENZYME | inhibitor | 252827481 | ||
65980 | BRD9 | ENZYME | 387065622 | |||
65980 | BRD9 | ENZYME | inhibitor | 315661231 |
Page: 1 |